MediXall Group(MDXL)
$0.380.00 (0.00%)
MDXL
MediXall Group financials statements
$0.38
At close:0.00 (0.00%)
MediXall Group (MDXL) Ratios
8 Followers
MediXall Group Ratios
MDXL's free cash flow for Q3 2024 was $-397.74K. For the 2024 fiscal year, MDXL's free cash flow was increased by $0.00 and operating cash flow was $-397.74K. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.00 | 0.28 | 1.01 | 0.90 |
| Quick Ratio | 0.00 | 0.00 | 0.28 | 1.01 | 0.90 |
| Cash Ratio | 0.00 | 0.00 | 0.05 | 0.58 | 0.90 |
| Solvency Ratio | -0.67 | -1.50 | -4.10 | -4.70 | -6.33 |
| Operating Cash Flow Ratio | -0.18 | -0.82 | -3.82 | -3.12 | -4.74 |
| Short-Term Operating Cash Flow Coverage | -0.32 | -1.39 | -67.65 | -138.07 | -32.82 |
| Net Current Asset Value | $ -6.71M | $ -4.52M | $ -1.13M | $ -127.79K | $ -94.00K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 19.05 | 3.27 | 0.28 | 0.13 | 0.13 |
| Debt-to-Equity Ratio | -0.59 | -0.77 | -0.93 | 0.56 | 0.30 |
| Debt-to-Capital Ratio | -1.42 | -3.32 | -12.89 | 0.36 | 0.23 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.27 | 0.00 |
| Financial Leverage Ratio | -0.03 | -0.23 | -3.33 | 4.30 | 2.36 |
| Debt Service Coverage Ratio | -0.87 | -2.31 | -88.41 | -233.64 | -47.88 |
| Interest Coverage Ratio | -6.05 | -24.12 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 75.30 | 0.03 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.04 | 0.03 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.98 | -0.43 | -0.04 | 0.07 | 0.10 |
| Profitability Margins | |||||
| Gross Profit Margin | 23.56% | -5296.21% | -20349.52% | 0.00% | -51065.21% |
| EBIT Margin | -1265.64% | -11067.18% | -41350.94% | 0.00% | -127409.72% |
| EBITDA Margin | -1254.56% | -11006.92% | -40835.90% | 0.00% | -127260.74% |
| Operating Profit Margin | -1265.64% | -11035.15% | -43561.27% | 0.00% | -127409.72% |
| Pretax Profit Margin | -1474.82% | -11524.63% | -41350.94% | 0.00% | -127409.72% |
| Net Profit Margin | -1474.82% | -11524.63% | -40245.78% | 0.00% | -127409.72% |
| Continuous Operations Profit Margin | -1474.82% | -11524.63% | -41350.94% | 0.00% | -127409.72% |
| Net Income Per EBT | 100.00% | 100.00% | 97.33% | 100.00% | 100.00% |
| EBT Per EBIT | 116.53% | 104.44% | 94.93% | 100.00% | 100.00% |
| Return on Assets (ROA) | -2269.19% | -792.38% | -533.31% | -360.95% | -364.71% |
| Return on Equity (ROE) | 69.95% | 186.15% | 1774.32% | -1553.28% | -860.05% |
| Return on Capital Employed (ROCE) | 60.03% | 187.95% | 6967.55% | -1135.86% | -770.42% |
| Return on Invested Capital (ROIC) | 145.40% | 770.88% | -14591.13% | -997.28% | -583.02% |
| Return on Tangible Assets | -16478.55% | -2327.78% | -887.25% | -492.67% | -588.52% |
| Earnings Yield | -8971.28% | -9.15% | -5.52% | -7.11% | -2.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.08 | 2.91 | 5.21 | 4.43 | 8.54 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 22.94 | 0.21 | 0.04 | 0.00 | 0.02 |
| Asset Turnover | 1.54 | 0.07 | 0.01 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | -0.06 | -0.02 | -0.03 | 0.00 | 0.04 |
| Cash Conversion Cycle | -4357.34 | -125.56 | -70.09 | -82.43 | -42.72 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 4357.34 | 125.56 | 70.09 | 82.43 | 42.72 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.03 | -0.04 | -0.04 | -0.03 |
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.05 | -0.04 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -2582.37 | -364.90 | -38.26 | -148.75 |
| Capital Expenditure Coverage Ratio | 0.00 | -2582.37 | -364.90 | -38.26 | -148.75 |
| Operating Cash Flow Coverage Ratio | -0.32 | -1.26 | -14.84 | -16.45 | -19.91 |
| Operating Cash Flow to Sales Ratio | -3.97 | -60.08 | -312.46 | 0.00 | -872.27 |
| Free Cash Flow Yield | -2417.19% | -4.77% | -4.29% | -4.31% | -1.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.01 | -10.93 | -18.13 | -14.06 | -43.34 |
| Price-to-Sales (P/S) Ratio | 0.16 | 1259.78 | 7296.71 | 0.00 | 55221.02 |
| Price-to-Book (P/B) Ratio | -0.01 | -20.35 | -321.69 | 218.33 | 372.76 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.04 | -20.96 | -23.29 | -23.19 | -62.88 |
| Price-to-Operating Cash Flow Ratio | -0.04 | -20.97 | -23.35 | -23.80 | -63.31 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -1.92 | 1.56 | -0.33 | -99.47 |
| Enterprise Value Multiple | -1.00 | -11.88 | -17.91 | -13.99 | -43.30 |
| Enterprise Value | 3.87M | 77.48M | 109.67M | 82.95M | 147.94M |
| EV to EBITDA | -1.00 | -11.88 | -17.91 | -13.99 | -43.30 |
| EV to Sales | 12.51 | 1307.32 | 7313.53 | 0.00 | 55098.65 |
| EV to Free Cash Flow | -3.15 | -21.75 | -23.34 | -23.07 | -62.75 |
| EV to Operating Cash Flow | -3.15 | -21.76 | -23.41 | -23.68 | -63.17 |
| Tangible Book Value Per Share | -0.05 | -0.04 | -0.01 | -0.00 | 0.00 |
| Shareholders’ Equity Per Share | -0.05 | -0.03 | -0.00 | 0.00 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.04 | -0.06 | -0.06 | -0.07 | -0.05 |
| Tax Burden | 1.00 | 1.00 | 0.97 | 1.00 | 1.00 |
| Interest Burden | 1.17 | 1.04 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.66 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 12.89 | 98.55 | 426.66 | 0.00 | 1275.10 |
| Stock-Based Compensation to Revenue | 5.04 | 33.15 | 90.88 | 0.00 | 239.57 |
| Income Quality | 0.27 | 0.52 | 0.76 | 0.59 | 0.68 |
Currency in USD
